Afton Hassett, PhD, delved into the relationship between the psychological impact of rheumatic diseases and their effects on individuals’ physical symptoms and overall well-being. She also discussed effective intervention strategies.
Jamie E. Collins, PhD, defined the types of artificial intelligence rheumatologists might encounter, as well as the potential benefits and risks of this quickly developing technology in healthcare applications.
The U.S. Food and Drug Administration approved indications for adult and pediatric rheumatology as well as new biosimilars and interchangeables for the treatment of rheumatic disease. Erick J. Gapud, MD, PhD, provided an overview of these drugs.
Michael Pfeffer, MD, FACP, discussed his experience piloting technology that utilizes artificial intelligence to listen to real-time conversations between healthcare providers and patients, transcribing the dialogue into text that can become a patient note.
In an opening message to ACR Convergence 2024 attendees, Dwinita Mosby Tyler, PhD, CEO and founder of The Equity Project, LLC, shared ways individuals can advance diversity, equity, and inclusion through education and self-reflection.
ACR Convergence is known for its innovative formats and sessions designed to engage the audience and facilitate active participation. ACR President Deborah Dyett Desir, MD, shares strategies for maximizing the attendee experience.
ACR Convergence attendees have the opportunity to sign up for these popular, interactive sessions for the first time in five years. The scientific program includes more than three dozen Meet the Professor sessions across 18 topic areas.
ACR President Deborah Dyett Desir, MD, shares her excitement for Convergence 2024. “This conference is the perfect venue for professionals to engage deeply with current trends and innovations, and to celebrate the achievements within our community,” she said.
ARP President Aileen Ledingham, PT, MS, PhD, outlines scientific sessions and activities that will be of particular interest to interprofessional team members when ACR Convergence convenes, including the ARP Business Meeting & Networking Lunch, ARP Keynote, Daltroy Lecture, and more.
Registration for this year’s premier rheumatology meeting is underway. Annual Meeting Planning Committee Chair Gregory C. Gardner, MD, MACP, shares some of the highlights among the scientific sessions and networking events that await attendees in Washington, D.C., this November.